Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood|April 9, 2015
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary taleYuhuan Wang, Vincent Hayes, Danuta Jarocha, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|March 27, 2023
Acute myocardial infarction reparation/regeneration strategy using Wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trialEwa Kwiecien, Leszek Drabik, Adam Mazurek, et al.
Blood|February 11, 2021
RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cellsBrian Estevez, Sara Borst, Danuta Jarocha, et al.
Cell Reports. Medicine|October 18, 2023
Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipientsAntonia Rotolo, Eoin C Whelan, Matthew J Atherton, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.
Circulation. Cardiovascular Imaging|December 29, 2012
Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imagingPiotr Musialek, Lukasz Tekieli, Magdalena Kostkiewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Haematologica|May 23, 2020
2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalanceAlisa Dong, Valentina Ghiaccio, Irene Motta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2021
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathiesLaura Breda, Valentina Ghiaccio, Naoto Tanaka, et al.
Blood|July 1, 2024
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapyMaxwell E Chappell, Laura Breda, Lucas Tricoli, et al.
Pageof 4